Mylène Cayol Selected Research

adrenomedullin (22-52)

2/2017	Stromal fibroblasts present in breast carcinomas promote tumor growth and angiogenesis through adrenomedullin secretion.
1/2016	Functional Analysis of the Adrenomedullin Pathway in Malignant Pleural Mesothelioma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mylène Cayol Research Topics

Disease

8	Neoplasms (Cancer) 11/2022 - 11/2013
3	Glioblastoma (Glioblastoma Multiforme) 01/2021 - 01/2014
2	Melanoma (Melanoma, Malignant) 11/2022 - 01/2014
1	Breast Neoplasms (Breast Cancer) 02/2017
1	Mesothelioma 01/2016
1	Malignant Mesothelioma 01/2016
1	Osteosarcoma (Osteogenic Sarcoma) 01/2014
1	Neoplasm Metastasis (Metastasis) 01/2014
1	Prostatic Neoplasms (Prostate Cancer) 11/2013

Drug/Important Bio-Agent (IBA)

6	AdrenomedullinIBA 11/2022 - 11/2013
3	Peptides (Polypeptides)IBA 11/2022 - 01/2016
2	Calcitonin Receptor-Like ProteinIBA 11/2022 - 01/2016
2	Receptor Activity-Modifying Protein 2IBA 11/2022 - 01/2016
2	AntibodiesIBA 11/2022 - 04/2015
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 11/2022 - 11/2013
2	cadherin 5IBA 01/2021 - 04/2015
2	Calcitonin Receptors (Calcitonin Receptor)IBA 02/2017 - 01/2016
2	adrenomedullin (22-52)IBA 02/2017 - 01/2016
1	matrigelIBA 11/2022
1	Blocking AntibodiesIBA 01/2021
1	Tyrosine (L-Tyrosine)FDA Link 01/2021
1	Immunoglobulin G (IgG)IBA 01/2021
1	Non-Receptor Type 11 Protein Tyrosine PhosphataseIBA 01/2021
1	OTX015IBA 11/2016
1	Messenger RNA (mRNA)IBA 01/2016
1	Receptor Activity-Modifying Protein 3IBA 01/2016
1	CateninsIBA 04/2015
1	Proteins (Proteins, Gene)FDA Link 01/2014
1	Hormones (Hormone)IBA 11/2013
1	AndrogensIBA 11/2013

Therapy/Procedure

5	Therapeutics 11/2022 - 11/2013
1	Immunotherapy 11/2022
1	Aftercare (After-Treatment) 11/2022
1	Drug Therapy (Chemotherapy) 11/2016
1	Injections 01/2014